By: Press Release
Source: http://online.wsj.com
MOUNTAIN VIEW, Calif., Oct. 17, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure(R) procedure, the most effective non-surgical permanent birth control method available, today announced that it has won a favorable jury verdict in its patent infringement lawsuit against Hologic, Inc. (Nasdaq:HOLX) in the United States District Court, Northern District of California. The jury has awarded Conceptus $18.8 million in monetary damages.
The jury found that use of Hologic's Adiana Permanent Contraception system infringed two claims of Conceptus' U.S. Patent Number 6,634,361 related to the Essure procedure, and that Hologic indirectly infringed those claims. The jury also upheld the validity of the claims.
Conceptus will seek an injunction prohibiting Hologic from importing, using, selling or offering to sell its Adiana system in the United States. This issue will be addressed by the Court in future proceedings.
"We are very pleased with the jury's verdict," said Mark Sieczkarek, president and chief executive officer of Conceptus. "Conceptus has always been proud of its Essure procedure, which brought a major advance to women's health, providing the most reliable form of permanent birth control to women without the need for incisions, hormones or general anesthesia. The jury verdict acknowledges the invention Conceptus pioneered more than a decade ago that is the foundation of the Essure procedure. We remain committed to continuously defending our intellectual property while we work to achieve our long-term goal of making Essure the standard of care in permanent birth control."
The Company will provide more detailed information as it becomes available and expects to make further comments during its upcoming third quarter financial results conference call on October 25, 2011.
Source: http://online.wsj.com/article/BT-CO-20111017-715997.html
Source: http://online.wsj.com
MOUNTAIN VIEW, Calif., Oct. 17, 2011 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure(R) procedure, the most effective non-surgical permanent birth control method available, today announced that it has won a favorable jury verdict in its patent infringement lawsuit against Hologic, Inc. (Nasdaq:HOLX) in the United States District Court, Northern District of California. The jury has awarded Conceptus $18.8 million in monetary damages.
The jury found that use of Hologic's Adiana Permanent Contraception system infringed two claims of Conceptus' U.S. Patent Number 6,634,361 related to the Essure procedure, and that Hologic indirectly infringed those claims. The jury also upheld the validity of the claims.
Conceptus will seek an injunction prohibiting Hologic from importing, using, selling or offering to sell its Adiana system in the United States. This issue will be addressed by the Court in future proceedings.
"We are very pleased with the jury's verdict," said Mark Sieczkarek, president and chief executive officer of Conceptus. "Conceptus has always been proud of its Essure procedure, which brought a major advance to women's health, providing the most reliable form of permanent birth control to women without the need for incisions, hormones or general anesthesia. The jury verdict acknowledges the invention Conceptus pioneered more than a decade ago that is the foundation of the Essure procedure. We remain committed to continuously defending our intellectual property while we work to achieve our long-term goal of making Essure the standard of care in permanent birth control."
The Company will provide more detailed information as it becomes available and expects to make further comments during its upcoming third quarter financial results conference call on October 25, 2011.
Source: http://online.wsj.com/article/BT-CO-20111017-715997.html
No comments:
Post a Comment